Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB) (Q2896292): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: budget (P474): 235,777.5 euro)
(‎Changed an Item: modifying budgets in portugal one item from slovenia)
Property / budget
 
471,555.0 Euro
Amount471,555.0 Euro
UnitEuro
Property / budget: 471,555.0 Euro / rank
 
Normal rank
Property / EU contribution
 
235,778.0 Euro
Amount235,778.0 Euro
UnitEuro
Property / EU contribution: 235,778.0 Euro / rank
 
Normal rank
Property / co-financing rate
 
50.0 percent
Amount50.0 percent
Unitpercent
Property / co-financing rate: 50.0 percent / rank
 
Normal rank

Revision as of 21:05, 21 October 2021

Project Q2896292 in Portugal
Language Label Description Also known as
English
Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB)
Project Q2896292 in Portugal

    Statements

    0 references
    235,778.0 Euro
    0 references
    471,555.0 Euro
    0 references
    50.0 percent
    0 references
    20 November 2019
    0 references
    31 August 2022
    0 references
    LIFEWELL - PHARMACEUTICAL & HEALTHCARE, LDA
    0 references
    0 references
    0 references

    40°50'20.44"N, 8°28'40.01"W
    0 references
    O presente projeto tem como objetivo o reforço das competências da LifeWell nos domínios da qualificação, da investigação e desenvolvimento e inovação (I&D&I) através da contratação de recursos altamente qualificados que contribuem para a consecução da estratégia de inovação, diversificação e crescimento sustentável da empresa, nos segmentos dos suplementos alimentares e medicamentos sujeitos a receita médica (MSRM). (Portuguese)
    0 references
    The present project aims to strengthen Lifewell’s skills in the areas of qualification, research and development and innovation (I &D&I) by hiring highly qualified resources that contribute to achieving the company’s innovation, diversification and sustainable growth strategy in the food supplements and prescription drugs (MSRM) segments. (English)
    8 July 2021
    0 references
    Oliveira de Azeméis
    0 references

    Identifiers

    NORTE-06-3559-FSE-000059
    0 references